maralixibat chloride sold brand name livmarli medication used treat cholestatic pruritus people alagille maralixibat chloride ileal bile acid transporter ibat common side effects include diarrhea abdominal pain belly maralixibat chloride approved medical use united states september european union december maralixibat chloride indicated treatment cholestatic pruritus patients alagille us food drug administration fda granted application maralixibat chloride orphan drug designations october committee medicinal products human use chmp european medicines agency ema adopted positive opinion recommending granting marketing authorization exceptional circumstances medicinal product livmarli intended treatment cholestatic pruritus patients alagille syndrome applicant medicinal product mirum pharmaceuticals international maralixibat chloride approved medical use european union december maralixibat chloride international nonproprietary name drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikimaralixibatchloride